Methods for induced abortion

Obstetrics and Gynecology

Volumn 104, Issue 1, 2004, Pages 174-185

  Stubblefield, Phillip G ^a,b   Carr Ellis, Sacheen ^a   Borgatta, Lynn ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BOSTON MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPROST TROMETAMOL; DIGOXIN; DILAPAN; DOXYCYCLINE; ERGOT ALKALOID; GEMEPROST; LAMICEL; METHOTREXATE; MIFEPRISTONE; MINOCYCLINE; MISOPROSTOL; NONSTEROID ANTIINFLAMMATORY AGENT; OXYTOCIN; POTASSIUM CHLORIDE; PROSTAGLANDIN E2; SULPROSTONE; TETRACYCLINE DERIVATIVE; VASOPRESSIN;

CURETTAGE; DEVICE; DIARRHEA; DRUG EFFICACY; EARLY DIAGNOSIS; ECHOGRAPHY; ELECTRIC UTERINE ASPIRATOR; FEVER; FORCEPS DELIVERY; GASTROINTESTINAL SYMPTOM; HEART INFARCTION; HUMAN; INDUCED ABORTION; INTRACARDIAC DRUG ADMINISTRATION; LAMINARIA; MULTIPLE PREGNANCY; OUTCOMES RESEARCH; PARACERVICAL BLOCK; PRIORITY JOURNAL; REVIEW; SECOND TRIMESTER PREGNANCY; TECHNIQUE; UNITED STATES; UTERINE CERVIX DILATATION; UTERUS PERFORATION; UTERUS RUPTURE; VOMITING; FEMALE; FIRST TRIMESTER PREGNANCY; GENERAL AND MISCELLANEOUS PROCEDURES AND TECHNIQUES; LABOR INDUCTION; METHODOLOGY; PREGNANCY;

ABORTION, INDUCED; DILATATION; FEMALE; HUMANS; LABOR, INDUCED; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PREGNANCY TRIMESTER, SECOND; VACUUM CURETTAGE;

EID: 3242656363     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.AOG.0000130842.21897.53     Document Type: Review

References (94)

1. Henshaw SK. Unintended pregnancy in the United States. Fam Plann Perspect 1998;30:24-9.
2. Finer LB, Henshaw SR. Abortion incidence and services in the United States in 2000. Perspect Sex Reprod Health 2003;35:6-15.
3. Elam-Evans LD, Strauss LT, Herndon J, Parker WY, Bowens SV, Zane S, et al. Abortion surveillance-United States, 2000. MMWR CDC Surveill Summ 2003;52(SS-12):1-32.
4. Stubblefield PG, Grimes DA. Septic abortion. N Engl J Med 1994;331:310-4.
5. Lawson HW, Frye A, Atrash HK, Smith JC, Shulman HB, Ramick M. Abortion mortality, United States, 1972-1987. Am J Obstet Gynecol 1994;171:1365-72.
6. Atrash HK, Cheek TG, Hogue CT. Legal abortion mortality and general anesthesia. Am J Obstet Gynecol 1988; 158:420-4.
7. Hakim-Elahi E, Tovell HM, Burnhill MS. Complications of first-trimester abortion: a report of 170,000 cases. Obstet Gynecol 1990;76:129-35.
8. Bartlett LA, Berg CJ, Shulman HB, Zane SB, Green CA, Whitehead S, et al. Risk factors for legal induced abortion-related mortality in the United States. Obstet Gynecol 2004;103:729-37.
9. Epner JE, Jonas HS, Seckinger DL. Later-term abortion. JAMA 1998;280:724-9.
10. Lichtenberg ES, Paul M, Jones H. First trimester surgical abortion practices: a survey of National Abortion Federation members. Contraception 2001;64:345-52.
11. Sawaya GF, Grady D, Kerlikowske K, Grimes DA. Antibiotics at the time of induced abortion: the case for universal prophylaxis based on a meta-analysis. Obstet Gynecol 1996;87:884-90.
12. Wiebe ER. Comparison of the efficacy of different local anesthetics and techniques of local anesthesia in therapeutic abortions. Am J Obstet Gynecol 1992;167:131-4.
13. Glantz JC, Shomento S. Comparison of paracervical block techniques during first trimester pregnancy termination. Int J Gynaecol Obstet 2001;72:171-8.
14. Schulz KF, Grimes DA, Christensen DD. Vasopressin reduces blood loss from second trimester dilatation and evacuation abortion. Lancet 1985;2:353-6.
15. United States Department of Health and Human Services. Warning for prescription drugs containing sulfite. FDA Drug Bull 1987;17:2-3.
16. Smith GM, Stubblefield PG, Chirchirillo L, McCarthy MJ. Pain of first trimester abortion: its quantification and relations with other variables. Am J Obstet Gynecol 1979;133: 489-98.
17. Suprapto K, Reed S. Naproxen sodium for pain relief in first-trimester abortion. Am J Obstet Gynecol 1984;150: 1000-1.
18. Keder LM. Best practices in surgical abortion. Am J Obstet Gynecol 2003;189:418-22.
19. Wong CYG, Ng EHY, Ngai SW, Ho PC. A randomized, double blind, placebo-controlled study to investigate the use of conscious sedation in conjunction with paracervical block for reducing pain in termination of first trimester pregnancy by suction evacuation. Hum Reprod 2002;17: 1222-5.
20. Rawling MJ, Wiebe ER. A randomized controlled trial of fentanyl for abortion pain. Am J Obstet Gynecol 2001;185: 103-7.
21. Schulz KF, Grimes DA, Cates W Jr. Measures to prevent cervical injury during suction curettage abortion. Lancet 1983;1:1182-5.
22. Ngai SW, Chan YM, Tang OS, Ho PC. The use of misoprostol for preoperative cervical dilatation prior to vacuum curettage: a randomized trial. Hum Reprod 1999; 14:2139-42.
23. MacIsaac L, Grossman D, Baliestreri E, Darney P. A randomized controlled trial of laminaria, oral misoprostol, and vaginal misoprostol before abortion. Obstet Gynecol 1999;93:766-70.
24. Edwards J, Darney PD, Paul M. Surgical abortion in the first trimester. In: Paul M, Lichtenberg ES, Borgatta L, editors. A clinician's guide to medical and surgical abortion. New York (NY): Churchill Livingston; 1999. p. 107-22.
25. Goldberg AB, Dean G, Rang MS, Youssoff S, Darney. Manual versus electric vacuum aspiration for early first-trimester abortion: a controlled study of complications rates. Obstet Gynecol 2004;103:101-7.
26. Stubblefield PG, Berek JS. Anatomical and clinical correlations of uterine perforations. Am J Obstet Gynecol 1979; 135:181-4.
27. Borgatta L, Chen AY, Reid SK, Stubblefield PG, Christensen DD, Rashbaum WK. Pelvic embolization for treatment of hemorrhage related to spontaneous and induced abortion. Am J Obstet Gynecol 2001;185:530-6.
28. Stubblefield PG, Borgatta L. Complications after induced abortion. In: Pearlman MD, Tintinalli JE, Dyne PL, editors. Emergency care of the woman: diagnosis and management. New York (NY): McGraw Hill; 2004. p. 65-86.
29. Sands RX, Burnhill MS, Hakim-Elahi E. Postabortal uterine atony. Obstet Gynecol 1974;43:595-8.
30. Thonneau P, Goyaux N, Goufodji S, Sundby J. Abortion and maternal mortality in Africa. N Engl J Med 2002;347: 1984-5.
31. Silvestre L, Dubois C, Renault M, Rezrani Y, Baulieu EE, Ulmann A. Voluntary interruption of pregnancy with mifepristone (RU 486) and a prostaglandin analogue: a large-scale French experience. N Engl J Med 1990;322: 645-8.
32. A death associated with mifepristone/sulprostone. Lancet 1991;337:969-70.
33. Goldberg AB, Greenberg MB, Darney PD. Drug therapy: misoprostol and pregnancy. N Engl J Med 2001;344: 38-47.
34. Schaff EA, Fielding SL, Eisinger SH, Stadalius LS, Fuller L. Low-dose mifepristone followed by vaginal misoprostol at 48 hours for abortion up to 63 days. Contraception 2000; 61:41-6.
35. Zieman M, Fong SK, Benowitz NL, Banskter D, Darney PD. Absorption kinetics of misoprostol with oral and vaginal administration. Obstet Gynecol 1997;90:88-92.
36. Schaff EA, Stadalius LS, Eisinger SH, Franks P. Vaginal misoprostol administered at home after mifepristone (RU 486) for abortion. J Fam Pract 1997;44:353-60.
37. Schaff EA, Fielding LS, Westhoff C, Ellertson C, Eisinger SH, Stadalius LS, et al. Vaginal misoprostol administered 1, 2, or 3 days after mifepristone for early medical abortion: a randomized trial. JAMA 2000;284:1948-53.
38. Creinin MD, Vittinghoff E, Keder L, Darney PD, Tiller G. Methotrexate and misoprostol for early abortion: a multicenter trial. I. Safety and efficacy. Contraception 1996;53: 321-7.
39. Borgatta L, Burnhill MS, Tyson J, Leonhardt KK, Hausknecht RU, Haskell S. Early medical abortion with methotrexate and misoprostol. Obstet Gynecol 2001;97: 11-6.
40. Jain JK, Dutton C, Harwood B, Meckstroth KR, Mishell DR Jr. A prospective randomized double blind controlled trial comparing mifepristone and vaginal misoprostol to vaginal misoprostol alone for elective termination of early pregnancy. Hum Reprod 2002;17:1477-82.
41. Orioli IM, Castilla EE. Epidemiological assessment of misoprostol teratogenicity. BJOG 2000;107:519-23.
42. Bawle EV, Conrad JV, Weiss L. Adult and two children with fetal methotrexate syndrome. Teratology 1998;57: 51-5.
43. Allen RH, Westhoff C, De Nonno L, Fielding SL, Schaff EA. Curettage after mifepristone-induced abortion: frequency, timing, and indications. Obstet Gynecol 2001;98: 101-6.
44. Hausknecht R. Mifepristone and misoprostol for early medical abortion: 18 months experience in the United States. Contraception 2003;67:463-5.
45. Grimes DA, Schulz KF, Cates W Jr, Tyler CW Jr. Mid-trimester abortion by dilatation and evacuation: a safe and practical alternative. N Engl J Med 1977;296:1141-5.
46. Hern WM. Operative procedures and technique. In: Hern WM, editor. Abortion practice. Philadelphia (PA): J. B. Lippincott Co (Reprinted by Alpenglow Graphics, Boulder, Colorado); 1990. p. 122-60.
47. Hern WM. Second trimester surgical abortion. In: Sciarra JJ, editor. Gynecology and obstetrics. Vol 6. Philadelphia (PA): Lippincott, Williams and Wilkins; 2003. p. 1-16.
48. Haskell WM, Easterling TR, Lichtenberg ES. Surgical abortion after the first trimester. In: Paul M, Lichtenberg ES, Borgatta L, Grimes DA, Stubblefield PG, editors. A clinician's guide to medical and surgical abortion. New York (NY): Churchill Livingston; 1999. p. 123-54.
49. Hanson MS. Mid-trimester abortion: dilatation and extraction preceded by laminaria. In: Zatuchni GI, Sciarra JJ, Sepidel JJ, editors. Pregnancy termination: procedures, safety and new developments. Hagerstown (MD): Harper & Row; 1979. p. 191-2.
50. Jackson RA, Teplin VL, Drey EA, Thomas LJ, Darney PD. Digoxin to facilitate late second trimester abortion: a randomized, masked, placebo-controlled trial. Obstet Gynecol 2001;97:471-6.
51. Schneider D, Halperin R, Langer R, Caspi E, Bukovsky I. Abortion at 18-22 weeks by laminaria dilatation and evacuation. Obstet Gynecol 1996;88:412-4.
52. Todd CS, Soler M, Castleman M, Rogers K, Blumenthal PD. Buccal misoprostol as a cervical preparation for second trimester pregnancy termination. Contraception 2002;65:415-8.
53. Stubblefield PG, Albrecht BH, Koos B, Fredericksen MC, Williford JF, Kayman DJ. A randomized trial of 12-mm and 15.9-mm cannulas in midtrimester abortion by laminaria and vacuum curettage. Fertil Steril 1978;29:512-7
54. Darney PD, Sweet RL. Routine intraoperative ultrasound for second trimester abortion reduces incidence of uterine perforation. J Ultrasound Med 1989;8:71-5.
55. Dark AC, Miller L, Kothenbeutel RL, Mandel L. Obesity and second trimester abortion by dilatation and evacuation. J Reprod Med 2002;47:226-30.
56. Halperin R, Vaknin Z, Langer R, Bukovsky I, Schneider DJ. Late midtrimester pregnancy termination in the presence of placenta previa. J Reprod Med 2003;48:175-8.
57. Schneider D, Bukovsky I, Caspi E. Safety of mid-trimester pregnancy termination by laminaria and evacuation inpatients with previous cesarean section. Am J Obstet Gynecol 1994;171:554-7.
58. Jacot FR, Poulin C, Bilodeau AP, Morin M, Moreau S, Gendron F, et al. A five-year experience with second-trimester induced abortions: no increase in complication rate as compared to the first trimester. Am J Obstet Gynecol 1993;168:633-7.
59. Pridmore BR, Chambers DG. Uterine perforation during surgical abortion: a review of diagnosis, management and prevention. Aust N Z J Obstet Gynaecol 1999;39:349-53.
60. Darney PD, Atkinson E, Hirabayashi K. Uterine perforation during second trimester abortion by cervical dilatation and instrumental extraction: a review of 15 cases. Obstet Gynecol 1990;75:441-4.
61. Kafrissen ME, Barke MW, Workman P, Schulz KF, Grimes DA. Coagulopathy and induced abortion method, rates and relative risks. Am J Obstet Gynecol 1983;147: 344-5.
62. Lawson HW, Atrash HK, Franks AL. Fatal pulmonary embolism during legal induced abortion in the United States from 1972 to 1985. Am J Obstet Gynecol 1990;162: 986-90.
63. Creinin MD. Labor induction termination of pregnancy. In: Sciarra JJ, editor. Gynecology and obstetrics. Vol 6. Philadelphia (PA), Lippincott, Williams and Wilkins; 2003. p. 1-20.
64. Ferguson JE 2nd, Burkett BJ, Pinkerton JV, Thiagarajah S, Flather MM, Martel MM, et al. Intraamniotic 15(s)-15-methyl prostaglandin F2 alpha and termination of middle and late second-trimester pregnancy for genetic indications: a contemporary approach. Am J Obstet Gynecol 1993;169:332-9.
65. Stubblefield PG, Naftolin F, Frigoletto F, Ryan KJ. Laminaria augmentation of intra-amniotic PGF2 for midtrimester pregnancy termination. Prostaglandins 1975;10: 413-22.
66. Osathanondh R. Conception control. In: Ryan KJ, Barbieri R, Berkowitz RS. Kistner's gynecology: principles and practice. 5th ed. Chicago (IL): Year Book Medical Publishers; 1990. p. 480-92.
67. 2. Contraception 1982;26:285-94.
68. 2 vaginal suppositories for second trimester pregnancy termination. Obstet Gynecol 1996;88:110-13.
69. Robins J, Mann LI. Midtrimester pregnancy termination by intramuscular injection of a 15-methyl analogue of prostaglandin F2 alpha. Am J Obstet Gynecol 1975;123: 625-31.
70. 2 for termination of second trimester pregnancy. N Engl J Med 1994;331:290-3.
71. Herabutya Y, O-Prasertsawat P. Second trimester abortion using intravaginal misoprostol. Int J Gynaecol Obstet 1998;60:161-5.
72. Wong KS, Ngai CSW, Yeo ELK, Tang LCH, Ho PC. A comparison of two regimens of intravaginal misoprostol for termination of second trimester pregnancy: a randomized comparative trial. Hum Reprod 2000;15:709-12.
73. Jain JK, Mishell DR Jr. A comparison of misoprostol with and without laminaria tents for induction of second trimester abortion. Am J Obstet Gynecol 1996;175:173-7.
74. Chen M, Shih J-C, Chiu W-T, Hsieh F-J. Separation of cesarean scar during second trimester intravaginal misoprostol abortion [case report]. Obstet Gynecol 1999;94: 840.
75. Berghahn L, Christensen D, Droste S. Uterine rupture during second-trimester abortion associated with misoprostol. Obstet Gynecol 2001;98:976-7.
76. Autry AM, Hayes EC, Jacobson GF, Kirby RS. A comparison of medical induction and dilatation and evacuation for second trimester abortion. Am J Obstet Gynecol 2002;187: 393-7.
77. Rouzi AA. Second-trimester pregnancy termination with misoprostol in women with previous cesarean sections. Int J Gynaecol Obstet 2003;80:317-8.
78. Pongsatha S, Tongsong T. Misoprostol for second trimester termination of pregnancies with prior low transverse cesarean section. Int J Gynaecol Obstet 2003;80:61-2.
79. Thong KJ, Baird DT. Induction of second trimester abortion with mifepristone and gemeprost. Br J Obstet Gynaecol 1993;100:758-61.
80. Ashok PW, Templeton A, Wagaarachchi PT, Flett GM. Midtrimester medical termination of pregnancy: a review of 1002 consecutive cases. Contraception 2004;69:51-8.
81. Tang OS, Thong KJ, Baird DT. Second trimester abortion with mifepristone and gemeprost: a review of 956 cases. Contraception 2001;64:29-32.
82. Webster D, Penny GC, Templeton A. A comparison of 600 and 200 mg mifepristone prior to second trimester abortion with the prostaglandin misoprostol. Br J Obstet Gynaecol 1996;103:706-9.
83. 2 vaginal suppositories. Obstet Gynecol 1991;77:297-300.
84. Drey EA, Thomas LJ, Benowitz NL. Goldschlager N, Darney PD. Safety of intra-amniotic digoxin administered before late second trimester abortion by dilatation and evacuation. Am J Obstet Gynecol 2000;182:1063-6.
85. 2. Am J Obstet Gynecol 1989;160:412-4.
86. Li YT, Yin CS. Delivery of retained placenta by misoprostol in second trimester abortion. Int J Gynaecol Obstet 2001;74:215-6.
87. Stubblefield PG. Management of intrauterine fetal death in the United States. In: Kuhn W, Rath W, editors. International colloquy on the management of intrauterine fetal death. Inter J Gynaecol 1987;25:185-97.
88. American College of Obstetricians and Gynecologists. Induction of labor with misoprostol. ACOG Committee Opinion 228. Washington, DC: ACOG; 1999.
89. Hsieh YY, Tsai HD, Chang CC, Yeh LS, Yang TC, Hsu TY. Precipitate delivery and postpartum hemorrhage after term induction with 200 μg misoprostol. Chung Huah I Hsueh Tsa Chih (Taipei) 2000;63:58-61.
90. O'Brien P, El-Refaey H, Gordon A, Geary M, Rodeck CH. Rectally administered misoprostol for the treatment of postpartum hemorrhage unresponsive to oxytocin and ergometrine: a descriptive study. Obstet Gynecol 1998;92: 212-4.
91. 2α: a randomized clinical trial. Am J Obstet Gynecol 1980;137:785-90.
92. 2α vs dilatation and evacuation. JAMA 1984;251:916-9.
93. Evans MI, Berkowitz RI, Wapner RJ, Carpenter RJ, Goldberg JD. Ayoub MA, et al. Improvements in outcomes of multifetal pregnancy reduction with increased experience. Am J Obstet Gynecol 2001;184:97-103.
94. Evans MI, Goldberg JD, Horenstein J, Wapner RJ, Ayoub MA, Stone J, et al. Selective termination for structural, chromosomal and Mendelian anomalies: international experience. Am J Obstet Gynecol 1999;181:893-7.